-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PspzlWwy2R/eeCgs5RcX3dLNiKx3k6m0D234NCebfhvt3Nmm4R74rMQ0Sfagieye GmKI1eUJhT37cRvrDJNdzw== 0001104659-06-060656.txt : 20060912 0001104659-06-060656.hdr.sgml : 20060912 20060912170151 ACCESSION NUMBER: 0001104659-06-060656 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060907 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20060912 DATE AS OF CHANGE: 20060912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroMetrix, Inc. CENTRAL INDEX KEY: 0001289850 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043308180 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50856 FILM NUMBER: 061086931 BUSINESS ADDRESS: STREET 1: 62 FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 890-9989 MAIL ADDRESS: STREET 1: 62 FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 8-K 1 a06-19517_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):   September 7, 2006

NEUROMETRIX, INC.

(Exact name of registrant as specified in charter)

Delaware

 

000-50856

 

04-3308180

(State or Other Jurisdiction

 

(Commission File Number)

 

(IRS Employer

of Incorporation)

 

 

 

Identification No.)

 

62 Fourth Avenue
Waltham, Massachusetts 02451
(Address of Principal Executive Offices) (Zip Code)

(781) 890-9989
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



 

Item   1.01   Entry Into a Material Definitive Agreement.

On September 7, 2006, the Compensation Committee of the Board of Directors of NeuroMetrix, Inc. (the “Company”) determined the following compensation information for certain executive officers of the Company regarding target cash bonuses for 2006.  This compensation information is as follows:

Name

 

Title

 

2006 Target Bonus
($ and % of Base Salary)(1)

 

Shai N. Gozani, M.D., Ph.D.

 

Chairman, President and Chief Executive Officer

 

$

131,250 (50%)

 

 

 

 

 

 

 

Gary Gregory

 

Chief Operating Officer

 

$

123,375 (50%)

 

 

 

 

 

 

 

W. Bradford Smith

 

Chief Financial Officer

 

$

69,300 (30%)

 

 

 

 

 

 

 

Guy Daniello

 

Senior Vice President of Information Technology

 

$

47,545 (25%)

 

 

 

 

 

 

 

Michael Williams

 

Senior Vice President of Engineering

 

$

49,612 (25%)

 

(1)             The award of cash bonuses in 2006 will be determined by the Compensation Committee based on the executive officer’s and the Company’s achievement of a number of objective and subjective goals specifically established for each executive officer by the Compensation Committee.

2



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

NEUROMETRIX, INC.

 

 

 

 

Dated: September 12, 2006

By:

 

/s/ Shai N. Gozani, M.D., Ph.D.

 

 

 

Shai N. Gozani, M.D., Ph.D.

 

 

President and Chief Executive Officer

 

3


 -----END PRIVACY-ENHANCED MESSAGE-----